Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction

Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction

US Patent 12018032 · Granted Jun 25, 2024

Estimated economic value: $5,120,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-invasive spinal cord stimulation for nerve root palsy, cauda equina syndrome2025
Accessing spinal networks to address sexual dysfunction2025
Compositions and dosage forms for treatment of HPV infection and HPV-induced neo2025
Multi-site transcutaneous electrical stimulation of the spinal cord for facilita2025
Inhibitors of menin-MLL interaction2025
Covalent inhibitors of menin-MLL interaction for diabetes mellitus2025
Covalent inhibitors of menin-MLL interaction for diabetes mellitus2025
Non invasive neuromodulation device for enabling recovery of motor, sensory, aut2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Pheny2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Pheny2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Pheny2025
Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Pheny2025